The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 334:1090-1094 April 25, 1996 Number 17
NextNext

A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis
Ethan J. Weiss, B.A., Paul F. Bray, M.D., Matthew Tayback, Sc.D., Steven P. Schulman, M.D., Thomas S. Kickler, M.D., Lewis C. Becker, M.D., James L. Weiss, M.D., Gary Gerstenblith, M.D., and Pascal J. Goldschmidt-Clermont, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Platelet glycoprotein IIb/IIIa is a membrane receptor for fibrinogen and von Willebrand factor, and it has an important role in platelet aggregation. It is known to be involved in the pathogenesis of acute coronary syndromes. Previously, we found a high frequency of a particular polymorphism, PlA2, of the gene encoding glycoprotein IIIa in kindreds with a high prevalence of premature myocardial infarction.

Methods To investigate the relation between the PlA2 polymorphism and acute coronary syndromes, we conducted a case–control study of 71 case patients with myocardial infarction or unstable angina and 68 inpatient controls without known heart disease. The groups were matched for age, race, and sex. We used two methods to determine the PlA genotype: reverse dot blot hybridization and allele-specific restriction digestion.

Results The prevalence of PlA2 was 2.1 times higher among the case patients than among the controls (39.4 percent vs. 19.1 percent, P = 0.01). In a subgroup of patients whose disease began before the age of 60 years, the prevalence of PlA2 was 50 percent, a value that was 3.6 times that among control subjects under 60 years of age (13.9 percent, P = 0.002). Among subjects with the PlA2 polymorphism, the odds ratio for having a coronary event was 2.8 (95 percent confidence interval, 1.2 to 6.4). In the patients less than 60 years of age at the onset of disease, the odds ratio was 6.2 (95 percent confidence interval, 1.8 to 22.4).

Conclusions We observed a strong association between the PlA2 polymorphism of the glycoprotein IIIa gene and acute coronary thrombosis, and this association was strongest in patients who had had coronary events before the age of 60 years.


Source Information

From the Department of Medicine, Divisions of Cardiology (E.J.W., S.P.S., L.C.B., J.L.W., G.G., P.J.G.-C.) and Hematology (E.J.W., P.F.B., T.S.K.), the Department of Pathology (P.F.B., T.S.K.), and the Department of Cell Biology and Anatomy (P.J.G.-C.), Johns Hopkins University School of Medicine; and Johns Hopkins University School of Hygiene and Public Health (M.T.) — both in Baltimore.

Address reprint requests to Dr. Goldschmidt-Clermont at Bernard Laboratory, Ross 1023, Johns Hopkins Medical School, 720 Rutland Ave., Baltimore, MD 21205.

Full Text of this Article


Related Letters:

Platelet Glycoprotein IIIa Pl A Polymorphism and Myocardial Infarction
Marian A.J., Brugada R., Kleiman N. S., Carter A. M., Ossei-Gerning N., Grant P. J., Goldschmidt-Clermont P. J., Bray P. F.
Extract | Full Text  
N Engl J Med 1996; 335:1071-1074, Oct 3, 1996. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.